Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 

Slides:



Advertisements
Similar presentations
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Advertisements

Volume 33, Issue 2, Pages (August 2010)
Volume 40, Issue 4, Pages (April 2014)
Volume 43, Issue 1, Pages (July 2015)
Volume 25, Issue 2, Pages (August 2006)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 12, Issue 8, Pages (August 2015)
Volume 31, Issue 5, Pages (November 2009)
Volume 39, Issue 2, Pages (August 2013)
Volume 37, Issue 3, Pages (September 2012)
Volume 13, Issue 6, Pages (November 2015)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 6, Issue 2, Pages (August 2009)
Volume 42, Issue 5, Pages (May 2015)
Monocyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania  Beatriz León,
Volume 18, Issue 1, Pages (July 2015)
Retinoic Acid Imprints Gut-Homing Specificity on T Cells
Yosuke Kamimura, Lewis L. Lanier  Cell Reports 
Volume 165, Issue 3, Pages (April 2016)
Volume 29, Issue 2, Pages (August 2008)
Volume 28, Issue 4, Pages (April 2008)
Volume 39, Issue 1, Pages (July 2013)
Volume 29, Issue 2, Pages (August 2008)
Volume 40, Issue 4, Pages (April 2014)
Volume 33, Issue 1, Pages (July 2010)
Volume 43, Issue 1, Pages (July 2015)
Volume 33, Issue 2, Pages (August 2010)
Volume 31, Issue 2, Pages (August 2009)
Volume 42, Issue 4, Pages (April 2015)
Volume 7, Issue 2, Pages (February 2010)
Volume 40, Issue 2, Pages (February 2014)
Volume 29, Issue 6, Pages (December 2008)
Volume 40, Issue 4, Pages (April 2014)
Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23- Driven Chronic Intestinal Inflammation  Thibault Griseri, Brent S.
Volume 29, Issue 5, Pages (November 2008)
Volume 33, Issue 5, Pages (November 2010)
Volume 41, Issue 5, Pages (November 2014)
Volume 29, Issue 1, Pages (July 2008)
Volume 17, Issue 3, Pages (October 2016)
Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention  Nu.
Volume 29, Issue 6, Pages (December 2008)
Volume 36, Issue 2, Pages (February 2012)
Volume 43, Issue 2, Pages (August 2015)
Volume 45, Issue 1, Pages (July 2016)
Volume 36, Issue 6, Pages (June 2012)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 41, Issue 4, Pages (October 2014)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 47, Issue 1, Pages e4 (July 2017)
Volume 32, Issue 1, Pages (January 2010)
Volume 10, Issue 1, Pages (July 2011)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Volume 29, Issue 4, Pages (October 2008)
Volume 31, Issue 4, Pages (October 2009)
Volume 46, Issue 4, Pages (April 2017)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 37, Issue 6, Pages (December 2012)
Volume 126, Issue 6, Pages (September 2006)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 5, Pages (May 2011)
Volume 40, Issue 5, Pages (May 2014)
Volume 28, Issue 5, Pages (May 2008)
Volume 38, Issue 6, Pages (June 2013)
Volume 38, Issue 2, Pages (February 2013)
Volume 22, Issue 8, Pages (February 2018)
Volume 31, Issue 5, Pages (November 2009)
Volume 13, Issue 6, Pages (November 2015)
Volume 35, Issue 1, Pages (July 2011)
Presentation transcript:

Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut  Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity  Volume 43, Issue 1, Pages 107-119 (July 2015) DOI: 10.1016/j.immuni.2015.06.009 Copyright © 2015 Elsevier Inc. Terms and Conditions

Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Homing Receptor Expression by ILCs in Lymphoid and Intestinal Tissues (A) Expression of CCR7, CCR9, and α4β7 by ILCs in secondary lymphoid tissues and the intestine. Total ILCs (Lin−CD90+CD127+) in the indicated organs and intestinal lamina propria of C57BL/6 mice (n = 10) were examined for expression of CCR7, CCR9, and α4β7. Isotype (IgG2a/b) antibodies were used for negative control staining. (B) Expression of homing receptors by ILC subsets in the spleen, MLN, SI, and colon. Data from Rag1−/− or C57BL/6 mice were essentially identical and combined (n = 15). Gating strategies for ILC1 (Lin−CD127+CD90+Eomes−RORγt−T-bet+), ILC2 (Lin−NK1.1−CD127+CD90+Sca-1+KLRG-1+GATA-3+), and ILC3 (T-bet− or T-bet+ Lin−CD127+CD90+RORγt+GATA-3−) subsets are shown in Figure S1. The “Lin” antibody mixture refers to the “common lineage markers” described in the Experimental Procedures section. ∗Significant differences (p < 0.05) from spleen (A) or ILC2 (B). ∗∗The spleen T-bet+ ILC3 population was very small (∼0.1% of Lin−CD127+CD90+ cells) and not shown. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 CCR7, CCR9, and Itg-β7 Are Required for Normal Numbers of ILCs in a Tissue-Specific Manner (A) Frequencies of Lin−CD90+CD127+ total ILCs in lymphoid tissues and the intestine of WT, Ccr7−/−, Ccr9−/−, or Itgb7−/− mice. (B) Frequencies of ILC subsets (ILC1, ILC2, and ILC3) in lymphoid tissues and the intestine of WT, Ccr7−/−, Ccr9−/−, or Itgb7−/− mice. (C) CD3−CD90+ ILCs in the SI of WT, Ccr9−/−, or Itgb7−/− mice were imaged by laser scanning confocal microscopy. Average numbers of CD3−CD90+ ILCs per villus and section are shown in the graph. The dot plots are shown for the Lin− cell gate, and the graphs are relative numbers of ILCs in Ccr7−/−, Ccr9−/−, or Itgb7−/− mice compared to WT mice (% of WT mice). The “Lin” mixture refers to the “common lineage markers.” Pooled data obtained from at least three different experiments (n = 15) are shown. ∗Significant differences (p < 0.05) from WT. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 RA Promotes Loss of CCR7 but Gain of CCR9 and α4β7 Expression in ILC3 and ILC1 but Not ILC2 (A) Induction of gut homing receptors and downregulation of CCR7 on ILCs by RA. Expression of homing receptors on Lin−CD90+CD127+ ILCs was assessed after the culture of spleen Lin− cells for 4 days with RA or Ro41-5253 (an RARα antagonist). (B) Induction of a homing receptor switch from CCR7 to CCR9 and α4β7 in cultured ILCs by RA. (C) Impact of RA and Ro41-5253 on homing receptor expression by ILC subsets. (D) Impact of RAR agonists and antagonists on homing receptor expression by ILC3 in vitro. (E) Chemotaxis of control, RA, or Ro41-5253-treated ILC subsets to CCL25. Spleen Lin− (or sorted ILC3 for panel C) cells were cultured with cecal bacterial extract, IL-7, and IL-15 for ILC1; IL-7 for ILC2; cecal bacterial extract, IL-7, and IL-23 for ILC3. The “Lin” mixture refers to the “common lineage markers.” Pooled data obtained from at least three different experiments are shown. ∗Significant differences (p < 0.05) from controls. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Mucosal DCs and Vitamin A Status Regulate the Expression of Homing Receptors by ILC3 and ILC1 (A) Mucosal DCs induce the homing receptor switch in ILC3. (B) Mucosal DCs induce the homing receptor switch in ILC1. CD11c+ DCs, freshly isolated from spleen or MLN, and spleen Lin− cells were co-cultured (ratio = 1:10, 4 days) for 4 days in the presence of Ro41-5253 or DEAB (an RALDH inhibitor) in the culture conditions described in Figure 3. Ro41-5253 or DEAB was added as indicated. (C) Expression of homing receptors by ILC subsets in the SI of VAN and VAD mice. Mice were fed with vitamin A-deficient (VAD) or normal (VAN) diets for 11–12 weeks before the examination of the ILC subsets. (D) Confocal imaging of ILCs in SI of VAN and VAD Rag1−/− mice. Average numbers of CD90+ ILCs per each villus and section are shown in the graph. Pooled data obtained from at least three different experiments (n = 3 for A,B; n = 8–12 for C; n = 12 for D) are shown. ∗Significant differences (p < 0.05) from control or VAN. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 BM ILC2P Can Directly Migrate to the Intestine and Their Expression of Gut Homing Receptors Is Not Affected by Vitamin A Status (A) Expression of CCR9 and α4β7 by BM ILC2P (Lin−CD127+Sca-1hiCD25+KLRG-1−) and more mature ILC2 lineage cells (Lin−CD127+Sca-1hiCD25+KLRG-1+) in VAN and VAD mice. (B) Tissue distribution of BM KLRG-1- and KLRG-1+ ILC2 lineage cells 44 hr after cell transfer (i.v.). (C) In vivo migration of WT versus homing receptor-deficient BM ILC2 lineage cells. Lin− Ly-6B.2− BM cells were injected i.v. into host mice and sacrificed 44 hr later in (B) and (C). The “Lin” mixture refers to the “BM lineage markers.” ∗Significant differences (p < 0.05) from WT. Pooled data obtained from 3–7 different experiments (n = 3–10) are shown. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 RA-Induced CCR9 and Itg-β7 Are Required for Short-Term Migration of ILC3 and Long-Term Population of ILC Subsets in the Intestine (A) Short-term (20 hr) homing of control versus RA-treated ILC3 to the intestine and secondary LT. (B) Short-term homing of WT versus homing receptor-deficient ILC3. Spleen cells, depleted of cells expressing the “splenocyte depletion markers” mentioned in the Experimental Procedures section, were cultured for 4 days in an ILC3 culture condition (commensal bacteria extract, IL-7, and IL-23) for 4 days. The cells, except Ccr7−/− and matching WT cells, were treated with RA for the homing experiment. (C) Impact of homing receptors on long-term population of ILC3, ILC1, and ILC2. A long-term competitive population study of WT and homing receptor-deficient ILC subsets following mixed (1:1) BM transfer from CD45.2+CD90.1+ WT and CD45.2+CD90.2+ homing receptor-deficient mice. The ILC subsets were examined in the indicated organs 8 weeks after the mixed BM transfer. Pooled data obtained from 2–3 different experiments (n = 7–10) are shown. ∗Significant differences (p < 0.05) from control or between WT and homing receptor-deficient ILCs. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 Gut Homing Receptors Are Required for Optimal ILC3 Effector Function during C. rodentium Infection (A) Protective effects of control and RA ILC3 in C. rodentium-infected VAD mice. Purified ILCs (Lin–NK1.1–KLRG-1–CD90hi), isolated from WT, Ccr9−/−, or Itgβ7−/− mice, were cultured with RA (10 nM) in an ILC3 culture condition (commensal bacteria extract, IL-7, and IL-23) for 4 days for the cell transfer. Control- and RA-treated ILC3 were transferred into VAD mice and infected with C. rodentium. Weight change and C. rodentium load were monitored. (B) Protective effects of WT versus gut homing receptor-deficient RA-ILCs on C. rodentium infection. Weight change, pathogen burden, and stool scores were determined. (C) Tissue distribution of Lin–CD90+CD127+RORγt+ ILC3 and (D) expression of ILC3 cytokines and antimicrobial peptides following adoptive transfer of WT or gut homing receptor-deficient ILC3 in VAD mice infected with C. rodentium. qRT-PCR was performed for panel D. The “Lin” mixture refers to the “splenocyte depletion markers.” Pooled data obtained from two different experiments (n = 7–8) are shown. ∗Significant differences between VAN and VAD or from the control (none) groups. All error bars represent SEM. Immunity 2015 43, 107-119DOI: (10.1016/j.immuni.2015.06.009) Copyright © 2015 Elsevier Inc. Terms and Conditions